Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04678167
Other study ID # 29BRC20.0040
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 10, 2021
Est. completion date March 10, 2027

Study information

Verified date July 2023
Source University Hospital, Brest
Contact Jean-Christophe LECLERE, Dr
Phone 02.98.22.33.78
Email jean-christophe.leclere@chu-brest.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.


Recruitment information / eligibility

Status Recruiting
Enrollment 51
Est. completion date March 10, 2027
Est. primary completion date March 10, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult patients, - patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea - patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear - patient with a postural deviation towards the affected ear; - vestibular hyporeflexia measured at the caloric tests greater than 25% - patient who has given free, enlighten and written consent Exclusion Criteria: - patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days - patient with associated hearing loss or tinnitus - patient with an motor ocular abnormality of central origin - patient refusal or inability to consent

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Caloric test
Lying, patientwill be placed so that he can introduce water (hot then cold) into his external ear canal. It is the reaction of the vestibular system (sensory organ responsible for balance) which is then measured with a helmet placed over his eyes and which measures the nystagmus (movement of the eye) which reflects vestibular activity.
Measurement of the speed of Nystagmus
A helmet with an infrared camera will be placed in front of patient eyes. This will allow visualizing on screen and measuring eye movements spontaneous or induced in the dark by various tests.
Angle of deviation at Fukuda
The patient will be asked to trample on the spot (30 steps) with the indexes pointed forward. In the event of vestibular asymmetry, the patient turns at a varying angle to the right or to the left. This will then measure what is called the angle of deflection of the fukuda.
Alexander's degree of nystagmus
there are 3 degrees: Degree I: nystagmus that exists only when the eyes are turned to the right. Degree II: also exists when the eyes are to the right or to the front. Degree Ill: exists when the eyes are on the right, front, or left
Other:
EHTEV questionnaire
Handicap Scale for Balance Disorders and Vertigo
EEV questionnaire
European Vertigo Assessment Questionnaire
anxiety VAS
visual analog scale of anxiety

Locations

Country Name City State
France CHU de Brest Brest
France CH Pays de Morlaix Morlaix
France CH de Cornouaille Quimper Quimper

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Variation of the angle of deviation at the Fukuda test between J0 and J7 (value at J0 minus value at J7). 7 day
Secondary Speed of nystagmus 1 year
Secondary Alexander's degree of nystagmus Measure of the degree of intensity of nystagmus. There are 3 degrees :
Degree I: nystagmus which exists only when the eyes are turned to the right.
Degree II: also exists when the eyes are to the right or to the front.
Degree Ill: exists when the eyes are on the right, front, or left.
1 year
Secondary Duration of hospitalization (for hospitalized patients) 1 year
Secondary Anxiety visual analog scale 0 = no anxiety, 10 = maximum anxiety imaginable 1 year
Secondary Handicap related to Balance Disorders and Vertigo scale (EHTEV questionnaire) It helps to determine the physical, emotional and functional difficulties experienced in everyday life. EHTEV questionnaire is scored on 100 points.
The physical score from 0 to 28 points, the emotional score from 0 to 36 points and the functional score from 0 to 36 points. ( 0 = no difficulty).
1 year
Secondary European Vertigo Evaluation Scale (EEV questionnaire) Makes it possible to quantify vertigo and the associated vestibular symptoms and to monitor their evolution. EEV questionnaire is scored on 20 points (0 = no symptoms, 20 = maximum symptoms) 1 year
Secondary Vestibular deficit at caloric tests measures 7of nystagmus (= fluttering of the eye) which reflects vestibular activity 1 year
Secondary Variation from J0 of the angle of deviation at the Fukuda measured at J14, M1, M3, M6, M12 1 year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02655575 - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Completed NCT02098330 - The Efficacy of Steroid Therapy in Vestibular Neuritis Phase 3
Not yet recruiting NCT05424302 - Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy N/A
Recruiting NCT01231009 - The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis Phase 0
Completed NCT03452410 - MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla
Recruiting NCT04926363 - Prevalence of Cardiovascular Risk Factors in Upper Vestibular Neuritis
Completed NCT03821155 - Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis? N/A
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Completed NCT02171312 - Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool N/A